The U.S. Justice Department is moving to block UnitedHealth Group Inc. (NYSE: UNH)’s $3.3 billion purchase of Amedisys Inc. (Nasdaq: AMED) over concerns the deal would harm competition in the market for home-health services, according to people familiar with the matter.
To read the entire story, you must be logged in.
Please log in now or register with us.
